Xiamen bnct therapy will accept patients in 2023. Because on February 4, 2021, the Xiamen Boron Neutron Capture Therapy (BNCT) Center was established. This marks the entry of BNCT into hospitals. On November 23, 2021, Chongqing Gaojin Biotechnology Co., Ltd. announced that the boron drug GJB01 has completed the research on raw materials and pharmaceutical preparations and achieved pilot mass production. This kind of treatment for melanoma, brain cancer, BPA boron medicine for malignant tumors such as glioma. It is expected to be used clinically in 2023.